|
Originally published In Press as doi:10.1074/jbc.M610615200 on February 8, 2007
J. Biol. Chem., Vol. 282, Issue 17, 12661-12668, April 27, 2007
Regulated Binding of Adenomatous Polyposis Coli Protein to Actin*
James B. Moseley ,
Francesca Bartolini 1,
Kyoko Okada ,
Ying Wen ,
Gregg G. Gundersen , and
Bruce L. Goode 2
From the
Department of Biology and Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, Massachusetts 02454 and the Departments of Anatomy & Cell Biology and Pathology, Columbia University, New York, New York 10032
Adenomatous polyposis coli (APC) protein is a large tumor suppressor that is truncated in most colorectal cancers. The carboxyl-terminal third of APC protein mediates direct interactions with microtubules and the microtubule plus-end tracking protein EB1. In addition, APC has been localized to actin-rich regions of cells, but the mechanism and functional significance of this localization have remained unclear. Here we show that purified carboxyl-terminal basic domain of human APC protein (APC-basic) bound directly to and bundled actin filaments and associated with actin stress fibers in microinjected cells. Actin filaments and microtubules competed for binding to APC-basic, but APC-basic also could cross-link actin filaments and microtubules at specific concentrations, suggesting a possible role in cytoskeletal cross-talk. APC interactions with actin in vitro were inhibited by its ligand EB1, and co-microinjection of EB1 prevented APC association with stress fibers. Point mutations in EB1 that disrupted APC binding relieved the inhibition in vitro and restored APC localization to stress fibers in vivo, demonstrating that EB1-APC regulation is direct. Because tumor formation and metastasis involve coordinated changes in the actin and microtubule cytoskeletons, this novel function for APC and its regulation by EB1 may have direct implications for understanding the molecular basis of tumor suppression.
Received for publication, November 15, 2006
, and in revised form, January 23, 2007.
* This work was supported in part by Grants GM63691 (to B. L. G.) and GM062939 (to G. G. G.) from the National Institutes of Health and by a grant from the March of Dimes (to B. L. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. S1.
1 Supported by Telethon-Italy Fellowship GFP03006.
2 To whom correspondence should be addressed: Rosenstiel Center, Brandeis University, 415 South St., Waltham, MA 02454. Tel.: 781-736-2464, Fax: 781-736-2405; E-mail: goode{at}brandeis.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. T. Yeung, B. B. Patel, X.-M. Li, S. H. Seeholzer, R. A. Coudry, H. S. Cooper, A. Bellacosa, B. M. Boman, T. Zhang, S. Litwin, et al.
One-Hit Effects in Cancer: Altered Proteome of Morphologically Normal Colon Crypts in Familial Adenomatous Polyposis
Cancer Res.,
September 15, 2008;
68(18):
7579 - 7586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Aoki and M. M. Taketo
Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene
J. Cell Sci.,
October 1, 2007;
120(19):
3327 - 3335.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|